Sable Bio
Latest round
- Seed
Last raised
- Sep 2025
Total raised
- $5.9M
Investors
- 3
About Sable Bio
Based in London, UK, and founded in 2023, Sable Bio Limited, also known as Sable, operates as an AI-enabled drug discovery company. The company was founded by Josh Almond-Thynne and Alex de Giorgio. Sable provides B2B (business-to-business) software solutions for biotech and pharma companies. The company’s product includes a drug discovery platform that uses artificial intelligence and large language models to analyze structured and unstructured data sources from multiple sources, including clinical trials, for personalized drug predictions and safety assessments.
Who invested in Sable Bio
3 investors across 1 round
See all investors in Sable Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 8, 2025
Amount
$5.9M
Investors
Questions about Sable Bio
Who invested in Sable Bio?
Sable Bio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sable Bio raised?
Sable Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sable Bio last raise money?
Sable Bio's most recent round on record is a Seed, in Sep 2025.
What does Sable Bio do?
Based in London, UK, and founded in 2023, Sable Bio Limited, also known as Sable, operates as an AI-enabled drug discovery company.
Where is Sable Bio headquartered?
Sable Bio is headquartered in London, UK.
Which VCs invest in companies like Sable Bio?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Balderton Capital and Sofinnova Partners back software companies at Sable Bio's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like Sable Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.